http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 19 Feb 2026 17:07:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Aurora+Daljit+Singh/26031046.html si-local-file:///var/storage/secattach/20260219/26031046.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Aurora+Daljit+Singh/26031046.html Thu, 19 Feb 2026 17:07:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Aurora+Daljit+Singh/26031046.html si-local-file:///var/storage/secattach/20260219/26031046.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Aurora+Daljit+Singh/26031046.html Thu, 19 Feb 2026 17:07:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Pinto+Joshua/26031038.html si-local-file:///var/storage/secattach/20260219/26031038.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Pinto+Joshua/26031038.html Thu, 19 Feb 2026 17:06:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Pinto+Joshua/26031038.html si-local-file:///var/storage/secattach/20260219/26031038.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Pinto+Joshua/26031038.html Thu, 19 Feb 2026 17:06:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+BERNS+PAUL+L/26031023.html si-local-file:///var/storage/secattach/20260219/26031023.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+BERNS+PAUL+L/26031023.html Thu, 19 Feb 2026 17:05:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+BERNS+PAUL+L/26031023.html si-local-file:///var/storage/secattach/20260219/26031023.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+BERNS+PAUL+L/26031023.html Thu, 19 Feb 2026 17:05:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Milligan+Michael+Lee/26031008.html si-local-file:///var/storage/secattach/20260219/26031008.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Milligan+Michael+Lee/26031008.html Thu, 19 Feb 2026 17:04:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Milligan+Michael+Lee/26031008.html si-local-file:///var/storage/secattach/20260219/26031008.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+17++Filed+by%3A+Milligan+Michael+Lee/26031008.html Thu, 19 Feb 2026 17:04:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Invus+Global+Management%2C+LLC/26030607.html si-local-file:///var/storage/secattach/20260219/26030607.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Invus+Global+Management%2C+LLC/26030607.html Thu, 19 Feb 2026 16:37:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Invus+Global+Management%2C+LLC/26030607.html si-local-file:///var/storage/secattach/20260219/26030607.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Invus+Global+Management%2C+LLC/26030607.html Thu, 19 Feb 2026 16:37:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+K2+HealthVentures+Equity+Trust+LLC/26014283.html si-local-file:///var/storage/secattach/20260217/26014283.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+K2+HealthVentures+Equity+Trust+LLC/26014283.html Tue, 17 Feb 2026 16:42:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+K2+HealthVentures+Equity+Trust+LLC/26014283.html si-local-file:///var/storage/secattach/20260217/26014283.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+K2+HealthVentures+Equity+Trust+LLC/26014283.html Tue, 17 Feb 2026 16:42:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pinto+Joshua/26013569.html si-local-file:///var/storage/secattach/20260217/26013569.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pinto+Joshua/26013569.html Tue, 17 Feb 2026 16:27:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pinto+Joshua/26013569.html si-local-file:///var/storage/secattach/20260217/26013569.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pinto+Joshua/26013569.html Tue, 17 Feb 2026 16:27:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+BERNS+PAUL+L/26013534.html si-local-file:///var/storage/secattach/20260217/26013534.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+BERNS+PAUL+L/26013534.html Tue, 17 Feb 2026 16:25:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+BERNS+PAUL+L/26013534.html si-local-file:///var/storage/secattach/20260217/26013534.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+BERNS+PAUL+L/26013534.html Tue, 17 Feb 2026 16:25:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013485.html si-local-file:///var/storage/secattach/20260217/26013485.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013485.html Tue, 17 Feb 2026 16:23:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013485.html si-local-file:///var/storage/secattach/20260217/26013485.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013485.html Tue, 17 Feb 2026 16:23:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013486.html si-local-file:///var/storage/secattach/20260217/26013486.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013486.html Tue, 17 Feb 2026 16:23:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013486.html si-local-file:///var/storage/secattach/20260217/26013486.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Aurora+Daljit+Singh/26013486.html Tue, 17 Feb 2026 16:23:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Milligan+Michael+Lee/26013440.html si-local-file:///var/storage/secattach/20260217/26013440.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Milligan+Michael+Lee/26013440.html Tue, 17 Feb 2026 16:22:00 -0500 NMRA O.59331052 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Milligan+Michael+Lee/26013440.html si-local-file:///var/storage/secattach/20260217/26013440.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Neumora+Therapeutics%2C++++++++++++++++++Filed+by%3A+Milligan+Michael+Lee/26013440.html Tue, 17 Feb 2026 16:22:00 -0500 NMRA O.59331052 http://www.streetinsider.com/Upgrades/William+Blair+Upgrades+Neumora+Therapeutics+%28NMRA%29+to+Outperform/26005332.html <p>William Blair analyst Myles R. Minter upgraded Neumora Therapeutics (NASDAQ: NMRA) from Market Perform to Outperform.</p><p>The analyst comments: "We are upgrading shares of Neumora from Market Perform to Outperform based on our updated model adjustments that suggest a favorable risk/reward and a risk-adjusted net present value of $7.62 per share.</p><p>We have increased our probability of success for NMRA-511 in Alzheimer’s disease agitation (AD-A) to 35% after Neumora presented data from its Phase Ib study, which showed meaningful reductions in the Cohen-Mansfield Agitation Inventory (CMAI) endpoint, though separation from placebo was most notable in a subgroup of patients with pronounced baseline http://www.streetinsider.com/Upgrades/William+Blair+Upgrades+Neumora+Therapeutics+%28NMRA%29+to+Outperform/26005332.html Tue, 17 Feb 2026 06:28:24 -0500 NMRA http://www.streetinsider.com/Analyst+Comments/William+Blair+Upgrades+Neumora+Therapeutics+%28NMRA%29+to+Outperform/26005332.html <p>William Blair analyst Myles R. Minter upgraded Neumora Therapeutics (NASDAQ: NMRA) from Market Perform to Outperform.</p><p>The analyst comments: "We are upgrading shares of Neumora from Market Perform to Outperform based on our updated model adjustments that suggest a favorable risk/reward and a risk-adjusted net present value of $7.62 per share.</p><p>We have increased our probability of success for NMRA-511 in Alzheimer’s disease agitation (AD-A) to 35% after Neumora presented data from its Phase Ib study, which showed meaningful reductions in the Cohen-Mansfield Agitation Inventory (CMAI) endpoint, though separation from placebo was most notable in a subgroup of patients with pronounced baseline http://www.streetinsider.com/Analyst+Comments/William+Blair+Upgrades+Neumora+Therapeutics+%28NMRA%29+to+Outperform/26005332.html Tue, 17 Feb 2026 06:28:24 -0500 NMRA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+11/25979185.html si-local-file:///var/storage/secattach/20260211/25979185.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Neumora+Therapeutics%2C+++++For%3A+Feb+11/25979185.html Wed, 11 Feb 2026 07:01:00 -0500 NMRA O.59331052